u/According-Swing-9430

Reddit r/ValueInvesting
· tracked since Jan 2026
Calls
1
Win Rate
0.0%
return
-29.9%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 0% Long 1 Short 0
Win Rate
7d 100%
30d 0%
90d 0%
Average Return -29.9% Long Return -29.9% Short Return -
Average Return
7d +1.7%
30d -21.7%
90d -34.6%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 20
$61.84
-29.9%
NVO long into Wegovy approvals
Author argues NVO is performing well despite Trump tariff threats and war risk, reading it as bullish momentum with most sellers exhausted. The claim is that the Wegovy Pill was not priced in at all, and upcoming catalysts include Wegovy Plus approval in the US, Wegovy Pill approval in the UK and EU, and Wegovy Plus approval in the EU. Author plans to sell parts of holdings after Wegovy Plus approval but before earnings, and would unload a big chunk at a 15-20% gain to reduce risk if approval slips.
GLP-1 / Obesity
Showing 1 of 1 calls · sorted by mentions

u/According-Swing-9430 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: NVO.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology